Role of liver transplantation in the treatment of cholangiocarcinoma

References

• Khan SA, Taylor-Robinson SD, Toledano MB, Beck A, Elliott P, Thomas HC. Changing international trends in mortality rates for liver, biliary and pancreatic tumours. J. Hepatol.37(6), 806–813 (2002).
   PubMed Web of Science ®Google Scholar
• Patel T. Worldwide trends in mortality from biliary tract malignancies. BMC Cancer2, 10 (2002).
   PubMed Web of Science ®Google Scholar
• Vauthey JN, Blumgart LH. Recent advances in the management of cholangiocarcinomas. Semin. Liver Dis.14(2), 109–114 (1994).
   PubMed Web of Science ®Google Scholar
• Khan SA, Davidson BR, Goldin R et al. Guidelines for the diagnosis and treatment of cholangiocarcinoma: consensus document. Gut51(Suppl. 6), VI1–VI9 (2002).
   PubMedGoogle Scholar
• Ben-Menachem T. Risk factors for cholangiocarcinoma. Eur. J. Gastroenterol. Hepatol.19(8), 615–617 (2007).
   PubMedGoogle Scholar
• Shaib YH, El-Serag HB, Nooka AK et al. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a hospital-based case-control study. Am. J. Gastroenterol.102(5), 1016–1021 (2007).
   PubMed Web of Science ®Google Scholar
• Kornfeld D, Ekbom A, Ihre T. Survival and risk of cholangiocarcinoma in patients with primary sclerosing cholangitis. A population-based study. Scand. J. Gastroenterol.32(10), 1042–1045 (1997).
   PubMed Web of Science ®Google Scholar
• Nashan B, Schlitt HJ, Tusch G et al. Biliary malignancies in primary sclerosing cholangitis: timing for liver transplantation. Hepatology23(5), 1105–1111 (1996).
   PubMed Web of Science ®Google Scholar
• Rosen CB, Nagorney DM, Wiesner RH, Coffey RJ Jr, LaRusso NF. Cholangiocarcinoma complicating primary sclerosing cholangitis. Ann. Surg.213(1), 21–25 (1991).
   PubMed Web of Science ®Google Scholar
• Patel AH, Harnois DM, Klee GG, LaRusso NF, Gores GJ. The utility of CA 19-9 in the diagnoses of cholangiocarcinoma in patients without primary sclerosing cholangitis. Am. J. Gastroenterol.95(1), 204–207 (2000).
   PubMed Web of Science ®Google Scholar
• Qin XL, Wang ZR, Shi JS, Lu M, Wang L, He QR. Utility of serum CA19-9 in diagnosis of cholangiocarcinoma: in comparison with CEA. World J. Gastroenterol.10(3), 427–432 (2004).
   PubMed Web of Science ®Google Scholar
• Nichols JC, Gores GJ, LaRusso NF, Wiesner RH, Nagorney DM, Ritts RE Jr. Diagnostic role of serum CA 19-9 for cholangiocarcinoma in patients with primary sclerosing cholangitis. Mayo Clin. Proc.68(9), 874–879 (1993).
   PubMed Web of Science ®Google Scholar
• Angulo P, Pearce DH, Johnson CD et al. Magnetic resonance cholangiography in patients with biliary disease: its role in primary sclerosing cholangitis. J. Hepatol.33(4), 520–527 (2000).
   PubMed Web of Science ®Google Scholar
• Fritscher-Ravens A, Bohuslavizki KH, Broering DC et al. FDG PET in the diagnosis of hilar cholangiocarcinoma. Nucl. Med. Commun.22(12), 1277–1285 (2001).
   PubMed Web of Science ®Google Scholar
• Fritscher-Ravens A, Broering DC, Knoefel WT et al. EUS-guided fine-needle aspiration of suspected hilar cholangiocarcinoma in potentially operable patients with negative brush cytology. Am. J. Gastroenterol.99(1), 45–51 (2004).
   PubMed Web of Science ®Google Scholar
• Zhang Y, Uchida M, Abe T, Nishimura H, Hayabuchi N, Nakashima Y. Intrahepatic peripheral cholangiocarcinoma: comparison of dynamic CT and dynamic MRI. J. Comput. Assist. Tomogr.23(5), 670–677 (1999).
   PubMedGoogle Scholar
• Malhi H, Gores GJ. Cholangiocarcinoma: modern advances in understanding a deadly old disease. J. Hepatol.45(6), 856–867 (2006).
   PubMed Web of Science ®Google Scholar
• Harewood GC, Baron TH, Stadheim LM, Kipp BR, Sebo TJ, Salomao DR. Prospective, blinded assessment of factors influencing the accuracy of biliary cytology interpretation. Am. J. Gastroenterol.99(8), 1464–1469 (2004).
   PubMed Web of Science ®Google Scholar
• Malhi H, Gores GJ. Review article: the modern diagnosis and therapy of cholangiocarcinoma. Aliment Pharmacol. Ther.23(9), 1287–1296 (2006).
   PubMed Web of Science ®Google Scholar
• Cheng JL, Bruno MJ, Bergman JJ, Rauws EA, Tytgat GN, Huibregtse K. Endoscopic palliation of patients with biliary obstruction caused by nonresectable hilar cholangiocarcinoma: efficacy of self-expandable metallic Wallstents. Gastrointest. Endosc.56(1), 33–39 (2002).
   PubMedGoogle Scholar
• Figueras J, Llado L, Valls C et al. Changing strategies in diagnosis and management of hilar cholangiocarcinoma. Liver Transpl.6(6), 786–794 (2000).
   PubMedGoogle Scholar
• Gerhards MF, den Hartog D, Rauws EA et al. Palliative treatment in patients with unresectable hilar cholangiocarcinoma: results of endoscopic drainage in patients with type III and IV hilar cholangiocarcinoma. Eur. J. Surg.167(4), 274–280 (2001).
   PubMedGoogle Scholar
• Kaiho T, Miyazaki M, Ito H et al. Treatment of unresectable hepatic hilar malignancies with self-expanding metallic stents. Hepatogastroenterology46(29), 2781–2790 (1999).
   PubMedGoogle Scholar
• Kuwayti K, Baggenstoss AH, Stauffer MH, Priestley JT. Carcinoma of the major intrahepatic and the extrahepatic bile ducts exclusive of the papilla of Vater. Surg. Gynecol. Obstet.104(3), 357–366 (1957).
   PubMedGoogle Scholar
• Schima W, Prokesch R, Osterreicher C et al. Biliary Wallstent endoprosthesis in malignant hilar obstruction: long-term results with regard to the type of obstruction. Clin. Radiol.52(3), 213–219 (1997).
   PubMedGoogle Scholar
• Berdah SV, Delpero JR, Garcia S, Hardwigsen J, Le Treut YP. A western surgical experience of peripheral cholangiocarcinoma. Br. J. Surg.83(11), 1517–1521 (1996).
   PubMedGoogle Scholar
• Isaji S, Kawarada Y, Taoka H, Tabata M, Suzuki H, Yokoi H. Clinicopathological features and outcome of hepatic resection for intrahepatic cholangiocarcinoma in Japan. J. Hepatobiliary Pancreat. Surg.6(2), 108–116 (1999).
   PubMedGoogle Scholar
• Nakagohri T, Asano T, Kinoshita H et al. Aggressive surgical resection for hilar-invasive and peripheral intrahepatic cholangiocarcinoma. World J. Surg.27(3), 289–293 (2003).
   PubMedGoogle Scholar
• Yeh CN, Jan YY, Yeh TS, Hwang TL, Chen MF. Hepatic resection of the intraductal papillary type of peripheral cholangiocarcinoma. Ann. Surg. Oncol.11(6), 606–611 (2004).
   PubMedGoogle Scholar
• Tan JC, Coburn NG, Baxter NN, Kiss A, Law CH. Surgical management of intrahepatic cholangiocarcinoma – a population-based study. Ann. Surg. Oncol.15(2), 600–608 (2008).
   PubMed Web of Science ®Google Scholar
• Murakami Y, Uemura K, Hayashidani Y et al. Prognostic significance of lymph node metastasis and surgical margin status for distal cholangiocarcinoma. J. Surg. Oncol.95(3), 207–212 (2007).
   PubMedGoogle Scholar
• Weber SM, Jarnagin WR, Klimstra D, DeMatteo RP, Fong Y, Blumgart LH. Intrahepatic cholangiocarcinoma: resectability, recurrence pattern, and outcomes. J. Am. Coll. Surg.193(4), 384–391 (2001).
   PubMed Web of Science ®Google Scholar
• Bismuth H, Nakache R, Diamond T. Management strategies in resection for hilar cholangiocarcinoma. Ann. Surg.215(1), 31–38 (1992).
   PubMed Web of Science ®Google Scholar
• Hemming AW, Reed AI, Fujita S, Foley DP, Howard RJ. Surgical management of hilar cholangiocarcinoma. Ann. Surg.241(5), 693–699; discussion 699–702 (2005).
   PubMedGoogle Scholar
• Jarnagin WR, Fong Y, DeMatteo RP et al. Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma. Ann. Surg.234(4), 507–517 (2001).
   PubMed Web of Science ®Google Scholar
• Kosuge T, Yamamoto J, Shimada K, Yamasaki S, Makuuchi M. Improved surgical results for hilar cholangiocarcinoma with procedures including major hepatic resection. Ann. Surg.230(5), 663–671 (1999).
   PubMedGoogle Scholar
• Silva MA, Tekin K, Aytekin F, Bramhall SR, Buckels JA, Mirza DF. Surgery for hilar cholangiocarcinoma; a 10 year experience of a tertiary referral centre in the UK. Eur J. Surg. Oncol.31(5), 533–539 (2005).
   PubMedGoogle Scholar
• Tsao JI, Nimura Y, Kamiya J et al. Management of hilar cholangiocarcinoma: comparison of an American and a Japanese experience. Ann. Surg.232(2), 166–174 (2000).
   PubMed Web of Science ®Google Scholar
• Guthrie CM, Haddock G, De Beaux AC, Garden OJ, Carter DC. Changing trends in the management of extrahepatic cholangiocarcinoma. Br. J. Surg.80(11), 1434–1439 (1993).
   PubMedGoogle Scholar
• Klempnauer J, Ridder GJ, von Wasielewski R, Werner M, Weimann A, Pichlmayr R. Resectional surgery of hilar cholangiocarcinoma: a multivariate analysis of prognostic factors. J. Clin. Oncol.15(3), 947–954 (1997).
   PubMedGoogle Scholar
• Kloek JJ, Ten Kate FJ, Busch OR, Gouma DJ, Van Gulik TM. Surgery for extrahepatic cholangiocarcinoma: predictors of survival. HPB (Oxford),10(3), 190–195 (2008).
   PubMedGoogle Scholar
• Todoroki T, Kawamoto T, Koike N et al. Radical resection of hilar bile duct carcinoma and predictors of survival. Br. J. Surg.87(3), 306–313 (2000).
   PubMed Web of Science ®Google Scholar
• Clary B, Jarnigan W, Pitt H, Gores G, Busuttil R, Pappas T. Hilar cholangiocarcinoma. J. Gastrointest. Surg.8(3), 298–302 (2004).
   PubMedGoogle Scholar
• Pandey D, Lee KH, Tan KC. The role of liver transplantation for hilar cholangiocarcinoma. Hepatobiliary Pancreat. Dis. Int.6(3), 248–253 (2007).
   PubMedGoogle Scholar
• Thelen A, Neuhaus P. Liver transplantation for hilar cholangiocarcinoma. J. Hepatobiliary Pancreat. Surg.14(5), 469–475 (2007).
   PubMedGoogle Scholar
• Starzl TE, Koep LJ. Surgical approaches for primary and metastatic liver neoplasms, including total hepatectomy with orthotopic liver transplantation. Prog. Clin. Cancer7, 181–193 (1978).
   PubMedGoogle Scholar
• Yokoyama I, Carr B, Saitsu H, Iwatsuki S, Starzl TE. Accelerated growth rates of recurrent hepatocellular carcinoma after liver transplantation. Cancer68(10), 2095–2100 (1991).
   PubMedGoogle Scholar
• Sudan DL. Transplantation for cholangiocarcinoma. Liver Transpl.12(11 Suppl. 2), S83–S84 (2006).
   Google Scholar
• Becker NS, Rodriguez JA, Barshes NR, O’Mahony CA, Goss JA, Aloia TA. Outcomes analysis for 280 patients with cholangiocarcinoma treated with liver transplantation over an 18-year period. J. Gastrointest. Surg.12(1), 117–122 (2008).
   PubMed Web of Science ®Google Scholar
• Rea DJ, Heimbach JK, Rosen CB et al. Liver transplantation with neoadjuvant chemoradiation is more effective than resection for hilar cholangiocarcinoma. Ann. Surg.242(3), 451–458 (2005).
   PubMed Web of Science ®Google Scholar
• Goss JA, Shackleton CR, Farmer DG et al. Orthotopic liver transplantation for primary sclerosing cholangitis. A 12-year single center experience. Ann. Surg.225(5), 472–481 (1997).
   PubMed Web of Science ®Google Scholar
• Robles R, Figueras J, Turrion VS et al. Spanish experience in liver transplantation for hilar and peripheral cholangiocarcinoma. Ann. Surg.239(2), 265–271 (2004).
   PubMed Web of Science ®Google Scholar
• Sansalone CV, Colella G, Caccamo L et al. Orthotopic liver transplantation for primary biliary tumors: Milan multicenter experience. Transplant Proc.26(6), 3561–3563 (1994).
   PubMedGoogle Scholar
• Meyer CG, Penn I, James L. Liver transplantation for cholangiocarcinoma: results in 207 patients. Transplantation69(8), 1633–1637 (2000).
   PubMed Web of Science ®Google Scholar
• Pascher A, Jonas S, Neuhaus P. Intrahepatic cholangiocarcinoma: indication for transplantation. J. Hepatobiliary Pancreat. Surg.10(4), 282–287 (2003).
   PubMedGoogle Scholar
• Brandsaeter B, Isoniemi H, Broome U et al. Liver transplantation for primary sclerosing cholangitis; predictors and consequences of hepatobiliary malignancy. J. Hepatol.40(5), 815–822 (2004).
   PubMed Web of Science ®Google Scholar
• Lindner P, Norrby J, Olausson M, Rizell M, Cahlin C, Friman S. Survival after liver transplantation for cholangiocarcinoma has increased during the last decade. Transplant Proc.35(2), 811–812 (2003).
   PubMedGoogle Scholar
• Pichlmayr R, Weimann A, Klempnauer J et al. Surgical treatment in proximal bile duct cancer. A single-center experience. Ann. Surg.224(5), 628–638 (1996).
   PubMed Web of Science ®Google Scholar
• Stieber AC, Marino IR, Iwatsuki S, Starzl TE. Cholangiocarcinoma in sclerosing cholangitis. The role of liver transplantation. Int. Surg,74(1), 1–3 (1989).
   PubMed Web of Science ®Google Scholar
• Casavilla FA, Marsh JW, Iwatsuki S et al. Hepatic resection and transplantation for peripheral cholangiocarcinoma. J. Am. Coll. Surg.185(5), 429–436 (1997).
   PubMed Web of Science ®Google Scholar
• Iwatsuki S, Klintmalm GB, Starzl TE. Total hepatectomy and liver replacement (orthotopic liver transplantation) for primary hepatic malignancy. World J. Surg.6(1), 81–85 (1982).
   PubMedGoogle Scholar
• Pichlmayr R, Weimann A, Ringe B. Indications for liver transplantation in hepatobiliary malignancy. Hepatology20(1 Pt 2), 33S–40S (1994).
   Google Scholar
• Pichlmayr R, Ringe B, Lauchart W, Bechstein WO, Gubernatis G, Wagner E. Radical resection and liver grafting as the two main components of surgical strategy in the treatment of proximal bile duct cancer. World J. Surg.12(1), 68–77 (1988).
   PubMed Web of Science ®Google Scholar
• Starzl TE, Todo S, Tzakis A et al. Abdominal organ cluster transplantation for the treatment of upper abdominal malignancies. Ann. Surg.210(3), 374–385 (1989).
   PubMedGoogle Scholar
• Alessiani M, Tzakis A, Todo S, Demetris AJ, Fung JJ, Starzl TE. Assessment of five-year experience with abdominal organ cluster transplantation. J. Am. Coll. Surg.180(1), 1–9 (1995).
   PubMedGoogle Scholar
• Neuhaus P, Blumhardt G. Extended bile duct resection – a new oncological approach to the treatment of central bile duct carcinomas? Description of method and early results. Langenbecks Arch. Chir.379(2), 123–128 (1994).
   PubMedGoogle Scholar
• Neuhaus P, Jonas S, Bechstein WO et al. Extended resections for hilar cholangiocarcinoma. Ann. Surg.230(6), 808–818 (1999).
   PubMed Web of Science ®Google Scholar
• Goldstein RM, Stone M, Tillery GW et al. Is liver transplantation indicated for cholangiocarcinoma? Am. J. Surg.166(6), 768–771 (1993).
   PubMedGoogle Scholar
• Jeyarajah DR, Klintmalm GB. Is liver transplantation indicated for cholangiocarcinoma? J. Hepatobiliary Pancreat. Surg.5(1), 48–51 (1998).
   PubMedGoogle Scholar
• De Vreede I, Steers JL, Burch PA et al. Prolonged disease-free survival after orthotopic liver transplantation plus adjuvant chemoirradiation for cholangiocarcinoma. Liver Transpl.6(3), 309–316 (2000).
   PubMed Web of Science ®Google Scholar
• Heimbach JK, Gores GJ, Haddock MG et al. Liver transplantation for unresectable perihilar cholangiocarcinoma. Semin. Liver Dis.24(2), 201–207 (2004).
   PubMed Web of Science ®Google Scholar
• Heimbach JK, Haddock MG, Alberts SR et al. Transplantation for hilar cholangiocarcinoma. Liver Transpl.10(10 Suppl. 2), S65–S68 (2004).
   Web of Science ®Google Scholar
• Heimbach JK, Gores GJ, Haddock MG et al. Predictors of disease recurrence following neoadjuvant chemoradiotherapy and liver transplantation for unresectable perihilar cholangiocarcinoma. Transplantation82(12), 1703–1707 (2006).
   PubMed Web of Science ®Google Scholar
• Sudan D, DeRoover A, Chinnakotla S et al. Radiochemotherapy and transplantation allow long-term survival for nonresectable hilar cholangiocarcinoma. Am. J. Transplant.2(8), 774–779 (2002).
   PubMed Web of Science ®Google Scholar
• Urego M, Flickinger JC, Carr BI. Radiotherapy and multimodality management of cholangiocarcinoma. Int. J. Radiat. Oncol. Biol. Phys.44(1), 121–126 (1999).
   PubMedGoogle Scholar
• Bismuth H. Revisiting liver transplantation for patients with hilar cholangiocarcinoma: the Mayo Clinic proposal. Liver Transpl.6(3), 317–319 (2000).
   PubMedGoogle Scholar
• Altaee MY, Johnson PJ, Farrant JM, Williams R. Etiologic and clinical characteristics of peripheral and hilar cholangiocarcinoma. Cancer68(9), 2051–2055 (1991).
   PubMed Web of Science ®Google Scholar
• Heimbach JK, Gores GJ, Nagorney DM, Rosen CB. Liver transplantation for perihilar cholangiocarcinoma after aggressive neoadjuvant therapy: a new paradigm for liver and biliary malignancies? Surgery140(3), 331–334 (2006).
   PubMedGoogle Scholar
• Schuller J, Cassidy J, Dumont E et al. Preferential activation of capecitabine in tumor following oral administration to colorectal cancer patients. Cancer Chemother. Pharmacol.45(4), 291–297 (2000).
   PubMed Web of Science ®Google Scholar
• Koutras AK, Talampuka G, Pagoni N et al. Capecitabine in pretreated metastatic cholangiocarcinoma. A case report and review of the literature. J. BUON12(2), 281–283 (2007).
   PubMedGoogle Scholar
• Patt YZ, Hassan MM, Aguayo A et al. Oral capecitabine for the treatment of hepatocellular carcinoma, cholangiocarcinoma, and gallbladder carcinoma. Cancer101(3), 578–586 (2004).
   PubMed Web of Science ®Google Scholar
• Stemmler J, Heinemann V, Schalhorn A. Capecitabine as second-line treatment for metastatic cholangiocarcinoma: a report of two cases. Onkologie25(2), 182–184 (2002).
   PubMedGoogle Scholar
• Jonas S, Neuhaus P. The perspective of liver transplantation for cholangiocarcinoma. Liver Transpl.13(10), 1358–1361 (2007).
   PubMedGoogle Scholar
• Mantel HT, Rosen CB, Heimbach JK et al. Vascular complications after orthotopic liver transplantation after neoadjuvant therapy for hilar cholangiocarcinoma. Liver Transpl.13(10), 1372–1381 (2007).
   PubMed Web of Science ®Google Scholar
• Gores GJ, Nagorney DM, Rosen CB. Cholangiocarcinoma: is transplantation an option? For whom? J. Hepatol.47(4), 455–459 (2007).
   PubMedGoogle Scholar
• Neuhaus P, Jonas S, Settmacher U et al. Surgical management of proximal bile duct cancer: extended right lobe resection increases resectability and radicality. Langenbecks Arch. Surg.388(3), 194–200 (2003).
   PubMedGoogle Scholar
• Volk ML, Vijan S, Marrero JA. A novel model measuring the harm of transplanting hepatocellular carcinoma exceeding Milan criteria. Am. J. Transplant.8(4), 839–846 (2008).
   PubMed Web of Science ®Google Scholar
• O’Grady JG. Treatment options for other hepatic malignancies. Liver Transpl.6(6 Suppl. 2), S23–S29 (2000).
   Google Scholar
• Kahaleh M, Mishra R, Shami VM et al. Unresectable cholangiocarcinoma: comparison of survival in biliary stenting alone versus stenting with photodynamic therapy. Clin. Gastroenterol. Hepatol.6(3), 290–297 (2008).
   PubMed Web of Science ®Google Scholar
• Nanashima A, Yamaguchi H, Shibasaki S et al. Adjuvant photodynamic therapy for bile duct carcinoma after surgery: a preliminary study. J. Gastroenterol.39(11), 1095–1101 (2004).
   PubMedGoogle Scholar
• Ortner ME, Caca K, Berr F et al. Successful photodynamic therapy for nonresectable cholangiocarcinoma: a randomized prospective study. Gastroenterology125(5), 1355–1363 (2003).
   PubMed Web of Science ®Google Scholar
• Wiedmann M, Berr F, Schiefke I et al. Photodynamic therapy in patients with non-resectable hilar cholangiocarcinoma: 5-year follow-up of a prospective Phase II study. Gastrointest. Endosc.60(1), 68–75 (2004).
   PubMed Web of Science ®Google Scholar
• Witzigmann H, Berr F, Ringel U et al. Surgical and palliative management and outcome in 184 patients with hilar cholangiocarcinoma: palliative photodynamic therapy plus stenting is comparable to R1/R2 resection. Ann. Surg.244(2), 230–239 (2006).
   PubMed Web of Science ®Google Scholar
• Zoepf T, Jakobs R, Arnold JC, Apel D, Riemann JF. Palliation of nonresectable bile duct cancer: improved survival after photodynamic therapy. Am. J. Gastroenterol.100(11), 2426–2430 (2005).
   PubMed Web of Science ®Google Scholar
• Wiedmann M, Caca K, Berr F et al. Neoadjuvant photodynamic therapy as a new approach to treating hilar cholangiocarcinoma: a Phase II pilot study. Cancer97(11), 2783–2790 (2003).
   PubMed Web of Science ®Google Scholar
• Iwatsuki S, Todo S, Marsh JW et al. Treatment of hilar cholangiocarcinoma (Klatskin tumors) with hepatic resection or transplantation. J. Am. Coll. Surg.187(4), 358–364 (1998).
   PubMed Web of Science ®Google Scholar
• Abu-Elmagd KM, Malinchoc M, Dickson ER et al. Efficacy of hepatic transplantation in patients with primary sclerosing cholangitis. Surg. Gynecol. Obstet.177(4), 335–344 (1993).
   PubMedGoogle Scholar
• Abu-Elmagd KM, Selby R, Iwatsuki S et al. Cholangiocarcinoma and sclerosing cholangitis: clinical characteristics and effect on survival after liver transplantation. Transplant Proc.25(1 Pt 2), 1124–1125 (1993).
   PubMed Web of Science ®Google Scholar
• Shimoda M, Farmer DG, Colquhoun SD et al. Liver transplantation for cholangiocellular carcinoma: analysis of a single-center experience and review of the literature. Liver Transpl.7(12), 1023–1033 (2001).
   PubMed Web of Science ®Google Scholar
• Haug CE, Jenkins RL, Rohrer RJ et al. Liver transplantation for primary hepatic cancer. Transplantation53(2), 376–382 (1992).
   PubMed Web of Science ®Google Scholar
• Ghali P, Marotta PJ, Yoshida EM et al. Liver transplantation for incidental cholangiocarcinoma: analysis of the Canadian experience. Liver Transpl.11(11), 1412–1416 (2005).
   PubMed Web of Science ®Google Scholar
• Pichlmayr R, Lamesch P, Weimann A, Tusch G, Ringe B. Surgical treatment of cholangiocellular carcinoma. World J. Surg.19(1), 83–88 (1995 ).
   PubMedGoogle Scholar
• Weimann A, Varnholt H, Schlitt HJ et al. Retrospective analysis of prognostic factors after liver resection and transplantation for cholangiocellular carcinoma. Br. J. Surg.87(9), 1182–1187 (2000).
   PubMedGoogle Scholar
• Ringe B, Wittekind C, Bechstein WO, Bunzendahl H, Pichlmayr R. The role of liver transplantation in hepatobiliary malignancy. A retrospective analysis of 95 patients with particular regard to tumor stage and recurrence. Ann. Surg.209(1), 88–98 (1989).
   PubMed Web of Science ®Google Scholar
• O’Grady JG, Polson RJ, Rolles K, Calne RY, Williams R. Liver transplantation for malignant disease. Results in 93 consecutive patients. Ann. Surg.207(4), 373–379 (1988).
   PubMed Web of Science ®Google Scholar
• Jonas S, Kling N, Guckelberger O, Keck H, Bechstein WO, Neuhaus P. Orthotopic liver transplantation after extended bile duct resection as treatment of hilar cholangiocarcinoma. First long-term results. Transpl. Int.11(Suppl. 1), S206–S208 (1998).
   Google Scholar
• Axelrod D, Koffron A, Kulik L et al. Living donor liver transplant for malignancy. Transplantation79(3), 363–366 (2005).
   PubMedGoogle Scholar